Home of Hepatology7 rue Daubin1203 GenevaSwitzerland+41 22 807 03 60easloffice@easloffice.eu© 2025 EASL. All rights reserved.Website by Soto.Privacy Policy | Cookie Policy | Terms & Conditions | Cyber Security Explore offerUnlock the full potential of being part of the EASLcommunity. As a member, you’ll gain access toexclusive resources, reduced event fees, top-tierjournals, and professional development opportunitiesdesigned to support your career in hepatologyBecome a memberNurses & Allied Health ProfessionalsLink titleYoung InvestigatorsLink titleBasic ScienceLink titleTitle here Lorem ipsum At the heart of EASL is a diverse and dynamic international community of professionals dedicated to advancing hepatology.Discover how you can get involved and make an impact.Whether you're a member, a Young Investigator, a nurse or allied health professional, or focused on basic science, there's a place for you here. Explore the different pathways to connect, grow and contribute, from membership benefits to tailored programmes and scientific networksLorem ipsum dolor sit ipsum CommunitySign In / Sign UpResourcesWhat We DoAbout Us Partnerships

Jhep

EASL News

Hepatic encephalopathy and traffic accidents

Hepatic encephalopathy (HE) is a frequent complication in patients with chronic liver disease. HE is a complication of cirrhosis that is associated with psychomotor slowing and an increased risk of accidents at home, at work, or while driving a car. Dr Formentin and colleagues aimed to evaluate t…

EASL News

A nuclear receptor links HIV drugs with liver disease

Before the advent of antiretroviral drugs, the prognosis for patients with AIDS was extremely poor. However, new antiretroviral treatments have revolutionised care for patients with HIV/AIDS, making lifelong viral suppression possible and improving life expectancy to near normal in patients treat…

EASL News

Physical activity linked to reduced risk of liver cancer

Liver cancer is a leading cause of cancer death, with hepatocellular carcinoma (HCC) accounting for 85–90% of all primary liver cancers. In a recent issue of Journal of Hepatology, Dr Baumeister et al. showed that higher total physical activity was associated with a reduced risk of HCC, an effect…

EASL News

To ward off fatty liver, breast is best for mom

Study finds fatty liver disease is less likely to occur in mothers who breastfeed for more than six months. Researchers at UC San Diego School of Medicine and Kaiser Permanente have discovered that mothers who breastfed a child or children for six months or more are at lower risk for developing n…

EASL News

Predicting the future burden of NAFLD and NASH

While the prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) continues to rise, with both conditions increasingly recognised in primary care and specialist practice, quantifying future disease burden has always been challenging. This is largely due to…

EASL News

Journal of Hepatology cited over 37,000 times in 2017

GENEVA, Switzerland 02 July 2018 – Last week Clarivate Analytics released the 2018 update of its Journal Citation Reports©, including the much anticipated 2017 impact factor. The Journal of Hepatology achieved exceptional results with a 2017 impact factor of 14.911, up from the 2016 score of 12.4…

Scroll to Top

Search EASL